CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 204 enrolled
Drug / intervention
Vitamin D2 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01633853
NCT01633853Phase 4Completed
CompareCT.gov

Study of Vitamin D2 Virus 1,25(OH)2-Vitamin D3 in the Treatment of Chronic Kidney Disease Mineral and Bone Disease

Dongliang Zhang, MD·interventional·Posted Jul 4, 2012·Updated Feb 15, 2016

In Brief

A Phase 4 clinical trial evaluating Vitamin D2 and 1,25(OH)2 Vit D3 for Vitamin D Deficiency. Completed, enrolled 204 participants across 1 site.

Detailed Summary

It is hypothesised that the efficacy and safety of Vitamin D2 soft capsule to treat the Chronic Kidney Disease Mineral and Bone Disease (CKD-MBD) are equal to 1,25(OH)2 Vitamin D3 (Rocaltrol) in the patients with CKD stage 3-5.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitamin D Deficiency
CountriesChina
CollaboratorsBeijing Municipal Science & Technology Commission

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 4, 2012
Enrollment StartJul 1, 2012
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 14.0 years ago

Interventions

Vitamin D2drug

Treatment with Vit D2.

1,25(OH)2 Vit D3drug

Treatment with 1,25(OH)2 Vitamin D3(Rocaltrol).